CEDILLA THERAPEUTICS
Cedilla is a developer of therapeutics technologies intended to broaden the reach of small molecule therapeutics. The company's technology is focused on destabilizing oncoprotein targets that are also applicable to therapies outside of oncology, enabling doctors to treat diseases caused by protein dysregulation. The company was founded in 2018 and based in Cambridge, Massachusetts.
CEDILLA THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2018-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.cedillatx.com
Total Employee:
11+
Status:
Active
Total Funding:
138.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Aditxt Therapeutics
Aditxt Therapeutics is a biotechnology company that develops a novel nucleic acid-based technology.
Aerpio Pharmaceuticals
Aerpio Pharmaceuticals is a biotechnology company that develops small molecules and monoclonal antibodies for vascular diseases treatment.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Affinia Therapeutics
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Alkermes
Alkermes is a biotechnology company that develops, manufactures and commercializes medicines for the treatment of chronic diseases.
Iterion Therapeutics
Iterion Therapeutics is a venture-backed, clinical-stage biotechnology company that develops novel targeted cancer therapeutics.
Casma Therapeutics
Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.
DermBiont
DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases.
Egle Therapeutics
Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Flare Therapeutics
Flare Therapeutics is a biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases.
Gismo Therapeutics
Gismo Therapeutics, a biotechnology startup, develops small-molecule therapeutics for the treatment of Alzheimer’s and Parkinson’s diseases.
IMMvention Therapeutix
IMMvention Therapeutix is a biotechnology company developing novel small molecule pan-inflammasome inhibitors for inflammatory diseases.
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
Kymera Therapeutics
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Ikena Oncology
Ikena Oncology is a biotechnology company that advances new immunometabolic therapies for cancer.
Ligature Therapeutics
Ligature Therapeutics is a biotech company that develops small molecules for targeted protein degradation to treat intractable diseases.
NovelMed Therapeutics
NovelMed Therapeutics is a biotechnology company developing novel therapies for orphan and non-orphan diseases.
Q32 Bio
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
QED Therapeutics
QED Therapeutics is a biotechnology company focused on precision medicine for FGFR-driven disorders.
Relay Therapeutics
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Motus Therapeutics
Motus Therapeutics is a biotechnology company developing peptide therapeutics for the treatment of metabolic diseases.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Silver Creek Pharmaceuticals
Silver Creek Pharmaceuticals is a biotechnology company, develops protein therapeutics to treat cardiovascular diseases.
Speratum
Speratum is a biotechnology company dedicated to research and development (R&D) of targeted molecular therapies for cancer treatment.
Theron Pharmaceuticals
Theron Pharmaceuticals is a biotechnology company that develops therapeutic products for the treatment of chronic respiratory diseases.
Trefoil Therapeutics
Trefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases.
Versartis
Versartis is a biotechnology company developing therapeutic proteins for the treatment of endocrine disorders.
Vesigen Therapeutics
Vesigen Therapeutics is a biotechnology company that develops groundbreaking therapeutic products.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
X-Biotix Therapeutics
X-Biotix Therapeutics is a biotechnology company specializing in the development of small molecule antibiotic scaffolds.
Current Advisors List
Board_member
2021-10-01
Board_member
Board_member
Current Employees Featured
Jack Taunton Founder @ Cedilla Therapeutics
Founder
William Kaelin Founder @ Cedilla Therapeutics
Founder
Matthew Jacobson Co-Founder @ Cedilla Therapeutics
Co-Founder
Brian Jones CSO @ Cedilla Therapeutics
CSO
Steve Gygi Founder @ Cedilla Therapeutics
Founder
Alexandra Glucksmann CEO & President @ Cedilla Therapeutics
CEO & President
Alan D'Andrea Co-Founder @ Cedilla Therapeutics
Co-Founder
2018-06-01
Founder
Investors List
Janus Henderson Investors
Janus Henderson Investors investment in Series B - Cedilla Therapeutics
Woodline Partners
Woodline Partners investment in Series B - Cedilla Therapeutics
RA Capital Management
RA Capital Management investment in Series B - Cedilla Therapeutics
Logos Capital
Logos Capital investment in Series B - Cedilla Therapeutics
Third Rock Ventures
Third Rock Ventures investment in Series B - Cedilla Therapeutics
Schroder Adveq
Schroder Adveq investment in Series B - Cedilla Therapeutics
Third Rock Ventures
Third Rock Ventures investment in Series B - Cedilla Therapeutics
Boxer Capital
Boxer Capital investment in Series B - Cedilla Therapeutics
Casdin Capital
Casdin Capital investment in Series B - Cedilla Therapeutics
Eli Lilly
Eli Lilly investment in Series B - Cedilla Therapeutics
Official Site Inspections
http://www.cedillatx.com
- Host name: 100.19.231.35.bc.googleusercontent.com
- IP address: 35.231.19.100
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Cedilla Therapeutics"
Cedilla Therapeutics - Crunchbase Company Profile
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.See details»
Cedilla Therapeutics: Contact Details and Business Profile
Cedilla Therapeutics is a Biotechnology Research, Biotechnology, and Protein company located in Cambridge, Massachusetts with 24 employees. Find top employees, contact details and …See details»
Cedilla Therapeutics Expands Leadership Team with …
Nov 16, 2021 Cedilla Therapeutics, a biotechnology company bringing a new dimension to precision oncology, today announced appointments across its research and devSee details»
Cedilla Therapeutics Company Profile | Management and
Find contact information for Cedilla Therapeutics. Learn about their Research & Development, Business Services market share, competitors, and Cedilla Therapeutics's email format.See details»
Cedilla Therapeutics | LinkedIn
Cedilla Therapeutics | 5,210 followers on LinkedIn. A New Dimension in Precision Oncology | For 60 years, sequence and structure has been the primary lens to understand protein function. …See details»
Cedilla Therapeutics Completes $82.6M Series B …
Oct 25, 2021 Cedilla Therapeutics, a biotechnology company bringing a new dimension to precision oncology, today announced that it has raised an additional $25 milSee details»
Cedilla Therapeutics Overview | SignalHire Company Profile
Cedilla Therapeutics is a private company that has been in the industry for 6 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the President …See details»
Cedilla Therapeutics - VentureRadar
"Cedilla Therapeutics is a private biotechnology company developing targeted small molecule medicines for the treatment of cancer and other diseases caused by protein dysregulation. …See details»
Cedilla Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Cedilla Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 16 news, Disease Domain:Neoplasms, Technology Platform:Small molecule drug, Drug:TEAD …See details»
Cedilla Therapeutics - Overview, News & Similar companies
Feb 3, 2022 View Cedilla Therapeutics (www.cedillatx.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Cedilla Therapeutics Expands Leadership Team with Key …
We have discovered new ways to selectively inhibit oncogenic drivers with small molecules that conditionally modulate proteins in their functional state. Our conditional inhibitors are unlocking …See details»
Cedilla’s Competitors, Revenue, Number of Employees, Funding
Cedilla’s Profile, Revenue and Employees. Cedilla is a Massachusetts-based biotechnology company that develops and commercializes small molecule therapeutics for the treatment of …See details»
Cedilla Therapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Cedilla Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Cedilla Therapeutics – Funding, Valuation, Investors, News
For 60 years, sequence and structure has been the primary lens to understand protein function. It’s now time to look beyond and leverage the orchestration of protein function within cells. …See details»
Cedilla Therapeutics Company Overview, Contact Details
Oct 25, 2021 Cedillatx hired Véronique Riethuisen as Chief Business Officer and Head of Finance on Nov 30th '20. Cedilla Therapeutics, a venture-backed preclinical biotechnology …See details»
Cedilla Therapeutics Completes $82.6M Series B Financing
Oct 25, 2021 Cedilla Therapeutics, a biotechnology company bringing a new dimension to precision oncology, announced that it has raised an additional $25 million in an expansion of …See details»
cedillatx.com Reviews | check if site is scam or legit| Scamadviser
Check cedillatx.com with our free review tool and find out if cedillatx.com is legit and reliable. Need advice? Report scams Check Scamadviser!See details»
Cedilla Therapeutics Expands Leadership Team - citybiz
Nov 16, 2021 We have discovered new ways to selectively inhibit oncogenic drivers with small molecules that conditionally modulate proteins in their functional state. Our conditional …See details»
Cedilla Therapeutics Unveils Lead Programs for the Conditional ...
Oct 21, 2021 Cedilla Therapeutics, a biotechnology company bringing a new dimension to precision oncology, today revealed its two lead conditional inhibitor prograSee details»
Cedilla Therapeutics Expands Leadership Team with Key
Nov 16, 2021 Cedilla Therapeutics today announced appointments across its research and development (R&D) and finance teams, including Joshua Murtie, Ph.D., as Vice President of …See details»